Codexis - Stock Price History | CDXS

Historical daily share price chart and data for Codexis since 2021 adjusted for splits. The latest closing stock price for Codexis as of September 27, 2021 is 24.95.
  • The all-time high Codexis stock closing price was 28.80 on February 08, 2021.
  • The Codexis 52-week high stock price is 29.56, which is 18.5% above the current share price.
  • The Codexis 52-week low stock price is 11.55, which is 53.7% below the current share price.
  • The average Codexis stock price for the last 52 weeks is 21.21.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Codexis Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 13.5535 16.4200 23.4100 8.7800 21.8300 36.52%
2019 17.2752 16.1100 22.1500 12.7500 15.9900 -4.25%
2018 14.0390 8.1500 22.5700 8.0000 16.7000 100.00%
2017 5.4064 4.5000 8.4000 3.8500 8.3500 81.52%
2016 4.1015 4.2200 5.1500 3.0100 4.6000 8.75%
2015 3.8360 2.7900 5.6400 2.7900 4.2300 67.86%
2014 1.9890 1.4300 2.8900 1.3400 2.5200 80.00%
2013 2.0560 2.5500 2.7200 1.2500 1.4000 -36.65%
2012 3.3962 5.4800 6.0800 2.0300 2.2100 -58.30%
2011 8.1521 10.5200 12.1900 4.2400 5.3000 -50.00%
2010 10.0184 13.2600 14.4500 7.1100 10.6000 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.613B $0.069B
Codexis is a leading protein engineering company that applies its proprietary CodeEvolver technology to develop proteins for a variety of applications, including as biocatalysts for the commercial manufacture of pharmaceuticals, fine chemicals and industrial enzymes, and enzymes as biotherapeutics and for use in molecular diagnostics. Codexis? proven technology enables improvements in protein performance, meeting customer needs for rapid, cost-effective and sustainable manufacturing in multiple commercial-scale implementations of biocatalytic processes.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29